End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
146.4 USD | -0.46% |
|
-0.46% | -4.75% |
27/06 | US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug | RE |
24/06 | US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit | RE |
Sales 2024 * | 88.75B 7,404B | Sales 2025 * | 92.27B 7,699B | Capitalization | 353B 29,481B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.98 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.83 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,31,900 |
Yield 2024 * |
3.31% | Yield 2025 * |
3.46% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | +0.61% | ||
1 week | -0.46% | ||
Current month | -0.46% | ||
1 month | +1.31% | ||
3 months | -9.59% | ||
6 months | -4.75% | ||
Current year | -4.75% |
![Extreme 146.4](/images/extremecours_fleche.png)
![Extreme 144.51](/images/extremecours_fleche.png)
![Extreme 144.51](/images/extremecours_fleche.png)
![Extreme 144.51](/images/extremecours_fleche.png)
![Extreme 144.51](/images/extremecours_fleche.png)
![Extreme 112](/images/extremecours_fleche.png)
![Extreme 112](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01/89/01 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01/98/01 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/19/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25/19/25 |
D. Davis
BRD | Director/Board Member | 72 | 19/14/19 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22/09/22 |
Date | Price | Change |
---|---|---|
26/24/26 | 146.4 | -0.46% |
25/24/25 | 147.1 | 0.00% |
24/24/24 | 147.1 | 0.00% |
21/24/21 | 147.1 | 0.00% |
20/24/20 | 147.1 | 0.00% |
End-of-day quote Lima, June 26, 2024
More quotes![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
+55.95% | 811B | |
+43.62% | 640B | |
+19.08% | 333B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B | |
-3.44% | 155B |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock